人类免疫缺陷病毒 (HIV)-1 治疗市场(关键地区、市场参与者、规模和份额)- 2031 年预测

  • Report Code : TIPRE00016876
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

市场介绍 人类免疫缺陷病毒(HIV)-1治疗剂是用于治疗HIV的药物。 HIV 是一种影响身体细胞的病毒感染,这些细胞有助于抵抗感染,并使身体更容易受到其他机会性感染。多种药物治疗类别可用于治疗人类免疫缺陷病毒。 市场动态 人类免疫缺陷病毒 (HIV)-1 治疗市场的主要市场驱动因素包括制药公司为开发新疗法而开展的广泛研发活动、全球感染传播率上升以及对 HIV 认识的缺乏发展中国家的感染是预计在预测期内推动市场增长的一些因素。然而,高昂的治疗成本、严格的药物治疗监管审批可能会抑制预测期内的市场增长。 s 市场范围 “人类免疫缺陷病毒 (HIV)-1 治疗市场”是对制药行业的专业和深入研究,特别注重全球市场趋势分析。该报告旨在概述人类免疫缺陷病毒 (HIV)-1 治疗市场,并按药物类别和应用详细进行市场细分。人类免疫缺陷病毒 (HIV)-1 治疗市场预计在预测期内将出现高速增长。该报告提供了人类免疫缺陷病毒(HIV)-1 治疗市场主要参与者的市场状况的关键统计数据,并提供了市场的主要趋势和机会。 市场细分 人类免疫缺陷病毒 (HIV)-1 治疗市场根据药物类别和应用进行细分。根据药物类别,市场分为 NRTIS、NNRTIS、进入和融合抑制剂、蛋白酶抑制剂、整合酶抑制剂。根据应用,市场分为医院、诊所等。

Human Immunodeficiency Virus (HIV)-1 Therapeutics Market: Strategic Insights

Human Immunodeficiency Virus (HIV)-1 Therapeutics Market
  • CAGR
    CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Gilead Sciences Inc
  • ViiV Healthcare
  • AbbVie Inc
  • Merck and Co Inc
  • Bristol Myers Squibb Company
  • Boehringer Ingelheim GmbH
  • Genentech Inc
  • Cipla Inc
  • janssen Pharmaceutica

Regional Overview

Regional And Country Scope
  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲
  • 中东和非洲

Market Segmentation

Segment 1药物类别
  • 核苷类似物逆转录酶抑制剂
Segment2申请
  • 医院
  • 诊所
  • 其他
Segment3地理
  • 北美洲
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲
该报告提供了行业的详细概述,包括定性和定量信息。它根据各个细分市场提供了人类免疫缺陷病毒 (HIV)-1 治疗市场的概述和预测。它还提供了 2021 年至 2031 年五个主要地区的市场规模和预测估计,即:北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 以及南美洲和中美洲。每个地区的人类免疫缺陷病毒 (HIV)-1 治疗市场随后按各自的国家和细分市场进行细分。该报告涵盖了对全球18个国家以及该地区当前趋势和机遇的分析和预测。该报告从需求和供应方面分析了影响人类免疫缺陷病毒(HIV)-1 治疗市场的因素,并进一步评估了预测期内影响市场的市场动态,即驱动因素、限制因素、机会和未来趋势。该报告还为所有五个地区提供了详尽的 PEST 分析,即:北美、欧洲、亚太地区、中东和非洲以及南美和中美洲在评估了影响这些地区人类免疫缺陷病毒 (HIV)-1 治疗市场的政治、经济、社会和技术因素后。 市场参与者 该报告涵盖了人类免疫缺陷病毒 (HIV)-1 治疗市场有机和无机增长策略的关键进展。许多公司都专注于有机增长战略,例如产品发布、产品批准以及专利和活动等其他战略。市场上出现的无机增长策略包括收购、伙伴关系和合作。这些活动为市场参与者扩大业务和客户群铺平了道路。随着全球市场对人类免疫缺陷病毒(HIV)-1 治疗市场的需求不断增长,预计人类免疫缺陷病毒(HIV)-1 治疗市场的市场参与者在未来将拥有利润丰厚的增长机会。下面提到的是从事人类免疫缺陷病毒(HIV)-1 治疗市场的几家公司的名单。该报告还包括人类免疫缺陷病毒 (HIV)-1 治疗市场主要参与者的概况以及他们的 SWOT 分析和市场策略。此外,该报告还重点关注领先的行业参与者,提供公司简介、组件和服务等信息,提供过去三年的财务信息、过去五年的主要发展信息。
    • 吉利德科学公司 • 默克公司 • 欢跃医疗保健 • 艾伯维公司• 布里斯托-迈尔斯施贵宝公司 • 勃林格殷格翰有限公司 • 基因泰克公司 • 西普拉公司 • 杨森制药 • 强生公司
The Insight Partner 的专门研究和分析团队由经验丰富的专业人士组成,拥有先进的统计专业知识,并在现有研究中提供各种定制选项。

Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Report Scope

Report Attribute Details
Market size in US$ XX million
Market Size by US$ XX Million
Global CAGR XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 药物类别
  • 核苷类似物逆转录酶抑制剂
By 申请
  • 医院
  • 诊所
  • 其他
By 地理
  • 北美洲
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太地区其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • Gilead Sciences Inc
  • ViiV Healthcare
  • AbbVie Inc
  • Merck and Co Inc
  • Bristol Myers Squibb Company
  • Boehringer Ingelheim GmbH
  • Genentech Inc
  • Cipla Inc
  • janssen Pharmaceutica
  • Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies

    1. Gilead Sciences, Inc
    2. ViiV Healthcare
    3. AbbVie, Inc
    4. Merck and Co., Inc
    5. Bristol-Myers Squibb Company
    6. Boehringer Ingelheim GmbH
    7. Genentech, Inc
    8. Cipla,Inc
    9. janssen Pharmaceutica
    10. Johnson and Johnson

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to Pharmaceuticals : READ MORE..